Co‐immunization with L‐Myc enhances CD8(+) or CD103(+) DCs mediated tumor‐specific multi‐functional CD8(+) T cell responses

Renal carcinoma shows a high risk of invasion and metastasis without effective treatment. Herein, we developed a chitosan (CS) nanoparticle‐mediated DNA vaccine containing an activated factor L‐Myc and a tumor‐specific antigen CAIX for renal carcinoma treatment. The subcutaneous tumor models were in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Dafei, Zhang, Zichun, Jiang, Nan, Ding, Jiage, Qiu, Dong, Shi, Shang Yuchen, Wang, Gang, Fang, Lin, Li, Huizhong, Tian, Hui, Yang, Jie, Zhang, Qing, Zheng, Junnian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409417/
https://www.ncbi.nlm.nih.gov/pubmed/34157192
http://dx.doi.org/10.1111/cas.15044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409417/
https://www.ncbi.nlm.nih.gov/pubmed/34157192
http://dx.doi.org/10.1111/cas.15044

Ejemplares similares